| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/06/2006 | EP1453520B1 Composition of estrogen and other hormones with ascorbate, lysine, proline and other substances |
| 09/06/2006 | EP1451208B1 Concentrating aqueous fractions of lisinopril by reverse osmosis |
| 09/06/2006 | EP1326632B1 Proteasome inhibitors for the treatment of hepatitis virus infections |
| 09/06/2006 | EP1282642B1 Therapeutic pore-forming peptides |
| 09/06/2006 | EP1257568B9 Novel echinocandin derivatives, preparation method and use thereof as fungicides |
| 09/06/2006 | EP1243595B1 Bh4-fused polypeptides |
| 09/06/2006 | EP1214350B1 Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy (dcm) |
| 09/06/2006 | EP1173224B1 Polyethyleneimine:dna formulations for aerosol delivery |
| 09/06/2006 | EP1131081A4 Stimulation of angiogenesis via syndecan-4 cytoplasmic domain signaling pathway |
| 09/06/2006 | EP1088075B1 Aav structural protein, production and use thereof |
| 09/06/2006 | EP1071449B1 Use of an antagonist antibody to the inflammatory mediator oncostatin m (osm) |
| 09/06/2006 | EP1027373B1 Muc-1 derivatives and their use in treating cancer-associated muc-1 mucin-induced immunosuppression |
| 09/06/2006 | EP1003546B1 Methods for treatment of patients afflicted wih multiple sclerosis using consensus interferon |
| 09/06/2006 | EP0955366B1 Antigenic protein originating in malassezia |
| 09/06/2006 | EP0914341B1 Antagonists of intestinotrophic glp-2 peptides |
| 09/06/2006 | EP0881912A4 Use of angiogenic lipids for vascularizing tissue |
| 09/06/2006 | EP0832232B9 Kunitz type plasma kallikrein inhibitors |
| 09/06/2006 | EP0789762B1 Methods for the diagnosis of glaucoma |
| 09/06/2006 | CN1829797A Compositions and methods for preventing and treating liver cirrhosis |
| 09/06/2006 | CN1829738A Novel insulin derivatives |
| 09/06/2006 | CN1829735A Imaging agents |
| 09/06/2006 | CN1829528A Compositions comprising gastrin compounds and their use in diabetes |
| 09/06/2006 | CN1829527A Cytokine inhibition function of eosinophils |
| 09/06/2006 | CN1829526A Soluble CLCA-1 and antagonists to CLCA-1 |
| 09/06/2006 | CN1829525A Immunotherapeutics for biodefense |
| 09/06/2006 | CN1829524A Anti-HIV-1 compounds based upon a conserved amino acid sequence shared by GP160 and the human CD4 protein |
| 09/06/2006 | CN1829523A Viral vectors |
| 09/06/2006 | CN1829453A Alimentation composition and use thereof |
| 09/06/2006 | CN1827763A Construction method for double-promoter yeast random peptide library for screening protein dissociation peptide |
| 09/06/2006 | CN1827649A Fusion toxin protein and uses thereof |
| 09/06/2006 | CN1827646A Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |
| 09/06/2006 | CN1827641A Antimicrobial polypeptide from Amolops loloensis and its pharmaceutical use |
| 09/06/2006 | CN1827640A Polypeptide for inhibition of angiogenesis and method for preparing same and use thereof |
| 09/06/2006 | CN1827639A 新的细胞因子zalpha11配体 New cytokine zalpha11 Ligand |
| 09/06/2006 | CN1827638A Vancomycin and nor-vancomycin derivatives and their preparation process and use |
| 09/06/2006 | CN1827637A Antibacterial polypeptide from Amolops loloensis and its pharmaceutical use |
| 09/06/2006 | CN1827635A Glycopeptide compositions |
| 09/06/2006 | CN1827168A Treatment of t cell mediated autoimmune disorders |
| 09/06/2006 | CN1827167A Animal medicine capable of increasing immunologic function of livestock and birds |
| 09/06/2006 | CN1827166A Animal medicine for resisting and treating poultry coccidiosis |
| 09/06/2006 | CN1827165A Animal medicine capable of increasing weight of meat chicken |
| 09/06/2006 | CN1827164A Animal medicine capable of rehabilitating intestinal tract injury |
| 09/06/2006 | CN1827163A Technique for preparing animal medicine with immunity-improving function |
| 09/06/2006 | CN1827162A Animal medicine capable of resisting multiple irritated stress of chicken |
| 09/06/2006 | CN1827161A Method for preparing trichosanthin injection |
| 09/06/2006 | CN1273614C Synaptic knob association membrane protein 25 and its use |
| 09/06/2006 | CN1273599C Thioredoxin peroxidase gene of China Qingdao branchiostoma and use thereof |
| 09/06/2006 | CN1273598C Bactericidal/permeability-increasing protein delation analogs |
| 09/06/2006 | CN1273587C Herpesvirus thymine deoxyriboside kinase mutant and use thereof |
| 09/06/2006 | CN1273485C Immunoglobulin sample receptor originated from human dendritic cell, its coding sequence and application |
| 09/06/2006 | CN1273444C Dipeptide nitriles |
| 09/06/2006 | CN1273191C Method and composition for altering a B cell mediated pathology |
| 09/06/2006 | CN1273187C Zinc-free or low-zinc preparation with improved stability |
| 09/06/2006 | CN1273186C Method for preparing injection without needle of interferon |
| 09/06/2006 | CN1273117C Controlled-releasing sticking plaster of natural interferon |
| 09/06/2006 | CN1273112C Fibrate-statin combinations with food-reducing and -fasting function |
| 09/06/2006 | CN1273030C Protein material for slow digestion and its use |
| 09/05/2006 | US7102059 Isolated nucleic acid molecule containing one open reading frame; a nucleotide sequence, or a complementary sequence encoding proteins or polypeptides of Pseudomonas CEL and EEL genomic regions or hybridizes to a DNA molecule |
| 09/05/2006 | US7101995 Drug delivery to inhibit abnormal gene expression in mammalian cells; small interfering RNAs (siRNA) |
| 09/05/2006 | US7101993 Oligonucleotides containing 2′-O-modified purines |
| 09/05/2006 | US7101990 Bax-responsive genes for drug target identification in yeast and fungi |
| 09/05/2006 | US7101988 Polyvalent cation-sensing receptor in Atlantic salmon |
| 09/05/2006 | US7101987 For controlling development, differentiation, trafficking, and physiology of mammalian cells; diagnosis |
| 09/05/2006 | US7101985 Methods and compositions in checkpoint signaling |
| 09/05/2006 | US7101979 Antibodies to antiangiogenic compositions and methods |
| 09/05/2006 | US7101977 Targeted killing of a cell utilizing a chimeric polypeptide comprising a cell-specific targeting moiety and a signal transduction pathway factor |
| 09/05/2006 | US7101975 Method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and β1 integrins |
| 09/05/2006 | US7101974 Tumor necrosis factor ptotein; for use in the treatment of rheumatic diseases and arthritis |
| 09/05/2006 | US7101973 β-amyloid peptide-binding proteins and polynucleotides encoding the same |
| 09/05/2006 | US7101972 With binding specificity for target nucleotides containing one or GNN triplets; regulating gene expression |
| 09/05/2006 | US7101971 Erythropoietin analog-human serum albumin fusion |
| 09/05/2006 | US7101965 Peptides of IL-2 |
| 09/05/2006 | US7101964 Vancomycin derivatives provide enhanced antibacterial activity, selectivity and reduced mammalian toxicity |
| 09/05/2006 | US7101963 Chlamydia pneumoniae polypeptides and uses thereof |
| 09/05/2006 | US7101962 Antibodies of the P2Y10 receptor useful in altering T lymphocyte function |
| 09/05/2006 | US7101880 Peptidic compounds as cysteine protease inhibitors |
| 09/05/2006 | US7101872 Farnesyl dibenzodiazepinone, and processes for its production |
| 09/05/2006 | US7101864 N-(2-acetamidoethyl)phosphonoformamide; inhibiting effect on zinc-containing proteinases, inhibiting cancer cells |
| 09/05/2006 | US7101860 Composition and method for inhibiting platelet aggregation |
| 09/05/2006 | US7101859 Use of lipid conjugates in the treatment of diseases |
| 09/05/2006 | US7101855 For therapy of inflammatory condition is selected from asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, multiple sclerosis, rheumatoid arthritis, tissue transplantation, tumor metastasis |
| 09/05/2006 | US7101854 Tetrapeptide stimulating the functional activity of hepatocytes, pharmacological substance on its basis and the method of its application |
| 09/05/2006 | US7101853 Provided amylin agonist is not calcitonin; also amylin used in combination with an nonsteroidal antiinflammatory agent to relieve pain, thereby achieving a synergistic effect |
| 09/05/2006 | US7101852 Composition and method for treatment and prevention of restenosis |
| 09/05/2006 | US7101851 IgE receptor antagonists |
| 09/05/2006 | US7101850 WISP polypeptides and nucleic acids encoding same |
| 09/05/2006 | US7101849 ωconotoxin peptides |
| 09/05/2006 | US7101848 Bicyclic oligopeptides |
| 09/05/2006 | US7101847 Administering to a human suffering from a chonic pelvic pain syndrom from prostatis a human chorionic gonadotropin or a pharmaceutically active fragment or derivative to alleviate one or more symptoms of the pain syndrome |
| 09/05/2006 | US7101846 Methods and compositions for optimization of oxygen transport by cell-free systems |
| 09/05/2006 | US7101845 Methods of modulating β cell function |
| 09/05/2006 | US7101844 Amino acid sequence with cell membrane transduction potential; higher than conventional protein transduction, remains in the cytoplasm |
| 09/05/2006 | US7101843 Amino acid sequence of His-Val-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Glu-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Ile-Lys-Gly-Arg-Gly-OH; obesity, stroke, myocardial infarction, irritable bowel syndrome, non-insulin dependent diabetes |
| 09/05/2006 | US7101842 Such as transferrin-doxorubicin conjugate linked by gluteraldehyde; inexpensive, effective |
| 09/05/2006 | US7101841 Shutting off recognition between cells by competitive binding inhibition; diagnosis of early stage cancer; inflammation, immune disease and cancer metastasis treatment; kits |
| 09/05/2006 | US7101839 Methods of and compositions for inhibiting the proliferation of mammalian cells |
| 09/05/2006 | US7101838 Method to prevent accelerated atherosclerosis using (sRAGE) soluble receptor for advanced glycation endproducts |
| 09/05/2006 | US7101837 Recombinant human alpha-fetoprotein as a cell proliferative agent |
| 09/05/2006 | US7101711 Activating a T gamma 9 delta 2 lymphocyte at a minimum activation concentration of below 100 nM, in vitro by contacting with a 3,4-epoxy-3-methyl-1-butyl diphosphate substituted with a biomolecule |
| 09/05/2006 | US7101709 Detecting modulator of cell proliferation, differentiation, viability, phenotypes or activity; prepare culture, incubate with modulator, monitor adjustment in cell characteristics, adjustment in characteristics indicate modulator |